Multimodality Therapy and Liver Transplantation in Patients With Cirrhosis and Hepatocellular Carcinoma: 6 Years, Single-Center Experience
โ Scribed by D.G. Maluf; R.T. Stravitz; B. Williams; A.H. Cotterell; V.R. Mas; D. Heuman; V. Luketic; M.L. Shiffman; R. Sterling; M.P. Posner; R.A. Fisher
- Book ID
- 116932849
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 545 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Orthotopic liver transplantation (OLT) selection for patients with hepatocellular carcinoma (HCC) is a matter of debate. The Milan criteria (MC) have been largely adopted by the international community. The main aim of this study was to evaluate the survival rates and recurrence probabilities of a n
The team of Liu et al. generated endoderm-derived human induced pluripotent stem (iPS) cells from primary hepatocytes. 1 However, they generated human iPS cells by using viral transgenes. 1 Clinical applications of human iPS cells require avoiding viral transgenes. On the other hand, the reprogrammi
1. The lack of whole-liver explant correlation has led to an overestimation of the sensitivity of imaging tests for the diagnosis of HCC in the radiological literature. 2. Ultrasound is insensitive for the diagnosis of HCC in the cirrhotic liver and should not be used for the detection of focal live